Germline Genomics in Thyroid Cancer: Controversies in Variant Pathogenicity, Clinical Utility of Genetic Screening, and Challenges for Clinical Implementation

Germline genomics has transformed the understanding of hereditary susceptibility to thyroid cancer; however, uncertainty persists regarding variant pathogenicity, the clinical utility of genetic screening, and the implementation of genomic medicine. This critical narrative review examines hereditary susceptibility genes, variant classification, genetic risk assessment, and implementation barriers from an international perspective, with particular attention to Latin American populations. Published genetic investigations, clinical guidance, and variant interpretation frameworks are synthesized. The evidence distinguishes the well-established role of RET in hereditary medullary thyroid carcinoma from recognized syndromic associations involving PTEN, APC, and DICER1 and from candidate susceptibility genes, including CHEK2, HABP2, SEC23B, and SRGAP1, for which the strength of validation varies. Germline variant interpretation requires the integration of population allele frequencies, functional evidence, familial segregation, gene–disease validity, and independent replication. Underrepresentation of diverse populations, inconsistent genomic reference information, and unequal access to specialized testing and counseling may restrict clinical translation, particularly in Latin America. The review concludes that meaningful clinical utility depends on validated hereditary associations, rigorous pathogenicity assessment, and evidence-based management pathways rather than the mere detection of additional inherited variants.

Authors

Publication Details

Journal
IECCMEXICO
Published
2026-11-15
DOI
https://doi.org/10.64784/406
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Germline Genomics in Thyroid Cancer: Controversies in Variant Pathogenicity, Clinical Utility of Genetic Screening, and Challenges for Clinical Implementation

Mauricio Zuluaga
IECCMEXICO
Thyroid Cancer Diagnosis and Treatment
article

Germline Genomics in Thyroid Cancer: Controversies in Variant Pathogenicity, Clinical Utility of Genetic Screening, and Challenges for Clinical Implementation

Mauricio Zuluaga
article en

Abstract

Germline genomics has transformed the understanding of hereditary susceptibility to thyroid cancer; however, uncertainty persists regarding variant pathogenicity, the clinical utility of genetic screening, and the implementation of genomic medicine. This critical narrative review examines hereditary susceptibility genes, variant classification, genetic risk assessment, and implementation barriers from an international perspective, with particular attention to Latin American populations. Published genetic investigations, clinical guidance, and variant interpretation frameworks are synthesized. The evidence distinguishes the well-established role of RET in hereditary medullary thyroid carcinoma from recognized syndromic associations involving PTEN, APC, and DICER1 and from candidate susceptibility genes, including CHEK2, HABP2, SEC23B, and SRGAP1, for which the strength of validation varies. Germline variant interpretation requires the integration of population allele frequencies, functional evidence, familial segregation, gene–disease validity, and independent replication. Underrepresentation of diverse populations, inconsistent genomic reference information, and unequal access to specialized testing and counseling may restrict clinical translation, particularly in Latin America. The review concludes that meaningful clinical utility depends on validated hereditary associations, rigorous pathogenicity assessment, and evidence-based management pathways rather than the mere detection of additional inherited variants.

IECCMEXICOVol. 5(2)
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon